ºÚÁÏÍø

Chronic Recurrent Multifocal Osteomyelitis (CRMO) is a rare and enigmatic pediatric condition characterized by recurrent episodes of bone inflammation, often leading to multifocal osteomyelitis, particularly in children and adolescents. CRMO is considered a part of the spectrum of autoinflammatory diseases, and its pathophysiology is thought to involve dysregulated immune responses, although the exact mechanisms remain unclear. The disease is typically associated with pain, swelling, and sometimes fever, though systemic manifestations are often mild or absent. Due to its nonspecific symptoms and the involvement of multiple skeletal sites, CRMO can often be misdiagnosed as bacterial osteomyelitis or other inflammatory disorders. Given the multifocal and recurrent nature of CRMO, radiological imaging plays a crucial role in confirming the diagnosis, evaluating the extent of the disease, and monitoring the progression or resolution of lesions over time. This article explores the role of radiological imaging, particularly advanced modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and bone scintigraphy, in the evaluation of CRMO in children [1].

Clinical Manifestations and Diagnosis of CRMO

The clinical presentation of CRMO typically involves recurrent bone pain and localized swelling, often in the metaphyseal regions of long bones such as the femur, tibia, and humerus. In some cases, the spine, pelvis, and clavicle may also be affected. The inflammatory episodes in CRMO tend to occur in a relapsing-remitting fashion, leading to challenges in both diagnosis and management. Although CRMO can be accompanied by fever and elevated inflammatory markers, these systemic symptoms are generally not as pronounced as in infectious osteomyelitis, and the condition often presents insidiously. Bone biopsy and histological examination are ultimately required to confirm the diagnosis, but radiological imaging remains pivotal in identifying the pattern of bone involvement and helping to differentiate CRMO from other mimicking conditions such as septic arthritis, bone tumors, or other forms of osteomyelitis [2].

Role of MRI in Evaluating CRMO

Magnetic resonance imaging (MRI) is the gold standard in evaluating bone and soft tissue involvement in CRMO, providing exceptional sensitivity and tissue contrast. MRI allows for the detection of early bone changes, even before radiographic alterations become apparent, making it essential in the diagnosis and monitoring of this disease. One of the characteristic MRI features of CRMO is the presence of bone marrow edema, which appears as areas of increased signal intensity on T2-weighted and short-tau inversion recovery (STIR) sequences. This bone marrow edema reflects the inflammatory process in the affected bones and is often seen in the metaphyseal regions, which are commonly involved in CRMO [3]. In the acute phase, the lesions may appear well-defined, but over time, they can become more confluent, affecting larger portions of the bone. Additionally, bone marrow edema may be accompanied by periosteal reaction, soft tissue swelling, and occasionally, cortical destruction, which may be evident on post-contrast sequences. One of the key advantages of MRI in CRMO is its ability to assess the extent of soft tissue involvement surrounding the affected bones. MRI can reveal periosteal thickening, which may indicate active inflammation, and it can also assess the degree of soft tissue edema or abscess formation, which can help distinguish CRMO from other forms of osteomyelitis. In some cases, MRI also enables the evaluation of spinal involvement, which may present as vertebral body edema or discitis [4]. Another important MRI feature is the potential for bilateral and multifocal lesions, which is characteristic of CRMO. MRI allows for comprehensive evaluation of multiple skeletal regions, helping to identify asymptomatic or subclinical lesions that may not be clinically apparent. These multifocal lesions, along with their recurrent nature, are essential in differentiating CRMO from other conditions, such as traumatic or metastatic bone lesions.

CT Imaging in CRMO

While MRI is the preferred imaging modality in the evaluation of CRMO, computed tomography (CT) can also play a complementary role, particularly in assessing bony architecture and detecting cortical destruction. CT is particularly useful for evaluating the extent of bone erosion, especially in the later stages of the disease when cortical breakdown or bone deformity may occur. CT scans are especially sensitive to detecting osseous involvement and can provide detailed images of the bone structure, which can help assess the severity of damage. In CRMO, CT may reveal bone sclerosis and cortical irregularities in addition to the erosive changes seen in more advanced stages. Unlike MRI, CT is less sensitive to detecting soft tissue changes, such as edema or periosteal thickening, which makes it less useful in assessing the inflammatory soft tissue component of CRMO. However, CT may be useful in cases where MRI findings are inconclusive or when precise information about the extent of bone damage is needed for surgical planning [5]. CT can also be employed in assessing complications of CRMO, such as pathological fractures or joint involvement, which may occur in some patients. Furthermore, the ability of CT to provide high-resolution images of bone lesions makes it valuable in evaluating unusual locations of CRMO, such as the skull or clavicle, which may be difficult to assess with other modalities.

Bone Scintigraphy in CRMO

Bone scintigraphy, or bone scan, is another radiological technique that can be useful in the initial evaluation of CRMO, particularly for detecting multifocal skeletal involvement. This technique involves the injection of a radiotracer, typically technetium-99m-labeled methylene diphosphonate (MDP), which is taken up by areas of increased bone turnover and inflammation. In CRMO, bone scintigraphy often demonstrates increased uptake in the affected bones, which correlates with areas of bone marrow edema and inflammation seen on MRI. Bone scintigraphy is valuable in detecting the extent of multifocal lesions and can help identify hidden or asymptomatic involvement, which is crucial for monitoring disease progression [6]. Although bone scintigraphy is sensitive to detecting active bone involvement, it is nonspecific and cannot provide detailed information about the exact nature of the lesions. For example, increased uptake on bone scans can be seen in a wide range of conditions, including infection, trauma, or malignancy, making it necessary to correlate scintigraphy results with clinical findings and other imaging modalities like MRI.

Challenges and Limitations of Radiological Imaging in CRMO

While radiological imaging is indispensable in the diagnosis and evaluation of CRMO, several challenges and limitations exist. One of the main challenges is the overlap in imaging findings with other conditions, such as infectious osteomyelitis or benign bone tumors, which can result in misdiagnosis. Bone scans, for example, can be positive in a variety of inflammatory conditions, making it essential to interpret these findings in conjunction with the clinical presentation and other imaging studies [7]. MRI, despite being the gold standard, can be limited in assessing the more advanced stages of CRMO, particularly in cases where there is significant cortical destruction or bone deformity, where CT may provide more detailed structural information. Moreover, the cost and accessibility of MRI can be limitations in certain settings, especially in resource-limited environments [8]. Another challenge is the need for long-term monitoring of patients with CRMO, as the recurrent nature of the disease requires repeated imaging, which may raise concerns about radiation exposure from CT scans or bone scintigraphy [9].

Conclusion

Radiological imaging plays a central role in the evaluation of Chronic Recurrent Multifocal Osteomyelitis (CRMO) in children, with MRI being the most valuable modality for detecting bone marrow edema, periosteal thickening, and soft tissue involvement. MRI allows for early detection of lesions and is highly sensitive to multifocal bone involvement, which is characteristic of CRMO. While CT and bone scintigraphy provide complementary information, particularly in assessing bony changes and detecting hidden lesions, MRI remains the primary tool for diagnosis and monitoring. Understanding the imaging characteristics of CRMO is critical for accurate diagnosis and effective management, allowing clinicians to differentiate this rare disease from other more common conditions and tailor appropriate treatment strategies. Further research is needed to refine imaging protocols and better understand the long-term implications of CRMO in pediatric patients.

1. Spaans AJ, Turkenburg JL, Wagenmakers R (2013). Radiol Case Rep 8: 793.

, ,

2. Hallel T, Lew S, Bansal M (1988) .J Bone Jt Surg 70: 264–270.

,

3. Hoffa A (1904) .JAMA 43: 795–796.

, Crossref

4. Arzimanoglu A (1957) .J Bone Joint Surg Am 39: 976–979.

,

5. Dogramaci Y, Kalaci A, Sevinç TT, Atik E, Esen E,  et al. (2009) .J Am Podiatr Med Assoc 99: 153–156.

, ,

6. Siva C, Brasington R, Totty W, Sotelo A, Atkinson J (2002) . J Rheumatol 29: 1088–1092.

,

7. Levadoux M, Gadea J, Flandrin P, Carlos E, Aswad R, et al. (2000) .J Hand Surg 25: 580–584.

, ,

8. Bejia I, Younes M, Moussa A, Said M, Touzi M, et al. (2005) .Skelet Radiol 34: 536–538.

, ,

9. Pandey T, Alkhulaifi Y (2006) .Australas Radiol 50: 487–489.

, ,